| Su-en C Thlick, Dmd | |
|
12701 Marblestone Dr Suite #260 Woodbridge VA 22192-8307 | |
| (703) 670-2114 | |
| Not Available |
| Full Name | Su-en C Thlick, Dmd |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 12701 Marblestone Dr, Woodbridge, Virginia |
| Authorized Official Name and Position | Su-en C Thlick (DENTIST/ OWNER) |
| Authorized Official Contact | 7036702114 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Su-en C Thlick, Dmd 12701 Marblestone Dr Suite #260 Woodbridge VA 22192-8307 Ph: (703) 670-2114 | Su-en C Thlick, Dmd 12701 Marblestone Dr Suite #260 Woodbridge VA 22192-8307 Ph: (703) 670-2114 |
| NPI Number | 1023207792 |
|---|---|
| Provider Enumeration Date | 10/18/2007 |
| Last Update Date | 10/18/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023207792 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (Virginia) | Primary |
News Archive
An international research team, led by investigators from the Massachusetts General Hospital (MGH) Cancer Center and Dana-Farber Cancer Institute (DFCI), has found a new way that some lung tumors become resistant to treatment with targeted therapy drugs like Iressa and Tarceva.
Health, family and romance problems appear to be the particular life stressors most associated with increased risk for using opioids to cope, and individuals with low self-esteem appear to be at risk for these connections, according to a new paper including researchers at Binghamton University, State University at New York.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
The deleterious effects that obesity has on an individual's health and the difficulty of reversing it in adults are well-known, ranging from diabetes and heart disease to cancer.
A clinical review, published today for the BMJ, provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions.
› Verified 1 days ago
Michael Morch D.d.s. P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3138 Golansky Blvd, Suite 101, Woodbridge, VA 22192 Phone: 703-878-7969 Fax: 703-730-9907 | |
Britto Orthodontics Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12581 Milstead Way, Suite 304, Woodbridge, VA 22192 Phone: 703-583-6784 Fax: 703-230-0509 | |
Renovasmiles Woodbridge Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 14007 Minnieville Rd, Woodbridge, VA 22193 Phone: 703-670-5414 Fax: 703-670-4545 | |
Neibauer Dental Care - Woodbridge Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 14901 Potomac Town Pl, Suite 175, Woodbridge, VA 22191 Phone: 703-580-5515 Fax: 703-583-1487 | |
Dental Professionals Of Virginia, P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12707 Ridgefield Village Dr Ste 101, Woodbridge, VA 22193 Phone: 571-989-6570 | |
Woodbridge Oral & Maxillofacial Surgery Center Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4585 Daisy Reid Ave Ste 105, Woodbridge, VA 22192 Phone: 703-670-6886 Fax: 703-670-3108 |